Literature DB >> 10437848

The human genome project and the future of diagnostics, treatment, and prevention.

G J van Ommen1, E Bakker, J T den Dunnen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10437848     DOI: 10.1016/s0140-6736(99)90241-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Genetics 101: detecting mutations in human genes.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Can mosaic tumor vessels facilitate molecular diagnosis of cancer?

Authors:  J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 3.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

4.  SMAD4 mutations found in unselected HHT patients.

Authors:  C J Gallione; J A Richards; T G W Letteboer; D Rushlow; N L Prigoda; T P Leedom; A Ganguly; A Castells; J K Ploos van Amstel; C J J Westermann; R E Pyeritz; D A Marchuk
Journal:  J Med Genet       Date:  2006-04-13       Impact factor: 6.318

5.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

Review 6.  Being more realistic about the public health impact of genomic medicine.

Authors:  Wayne D Hall; Rebecca Mathews; Katherine I Morley
Journal:  PLoS Med       Date:  2010-10-12       Impact factor: 11.069

7.  Challenges in prevention, diagnosis and therapy of emerging fungal diseases. Aspergillosis: A case study.

Authors:  P U Sarma; P V Sarma; T Madan
Journal:  Indian J Clin Biochem       Date:  2000-08

8.  Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases.

Authors:  Kathleen L Miller; Lewis J Fermaglich; Janet Maynard
Journal:  Orphanet J Rare Dis       Date:  2021-06-09       Impact factor: 4.123

9.  Genetics in public health: Rarely explored.

Authors:  Y B Aswini; S Varun
Journal:  Indian J Hum Genet       Date:  2010-05

Review 10.  Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma.

Authors:  L J Palmer; W O Cookson
Journal:  Respir Res       Date:  2001-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.